Baycol

Type: Product
Name: Baycol
First reported Aug 26 2014 - Updated Aug 26 2014 - 1 reports

Keller Rohrback L.L.P. Investigates Life-Threatening Complications From Xarelto Drug Use

World News: 01:03 GMT Tuesday 26th August 2014 . [ Keller Rohrback L.L.P. via Globe Newswire via SPi World News ]This storySEATTLE, Aug. 25, 2014 (GLOBE NEWSWIRE)Attorney Advertising. The blood-thinning drug Xarelto is under scrutiny for causing uncontrollable ... [Published SPi World News - Aug 26 2014]
First reported Aug 19 2014 - Updated Aug 19 2014 - 1 reports

Pfizer sued for hiding side-effects of cholesterol drug Lipitor

© InconnuPharmaceutical giant Pfizer is facing a mounting wave of lawsuits by women who allege that the company knew about possible serious side effects of its blockbuster anti-cholesterol drug Lipitor but never properly warned the public.In the past ... [Published Sott.net - Aug 19 2014]
First reported Aug 09 2014 - Updated Aug 10 2014 - 1 reports

Pfizer (NYSE:PFE) Seeing a Surge Of Lawsuits Over Lipitor

Pharmaceutical giant Pfizer (NYSE:PFE) is facing a mounting number of lawsuits by women who allege that the company knew about possible serious side effects of its anti-cholesterol drug Lipitor but never properly warned the public.In the past 5 months, ... [Published Live Trading News - Aug 09 2014]
First reported Aug 08 2014 - Updated Aug 09 2014 - 2 reports

Pfizer faces growing legal threat over Lipitor

Cases of women claiming Lipitor gave them diabetes swell to 1,000 in a few monthsShareToolsSales of Lipitor, the best-selling drug of all time, may be waning, but litigation over the cholesterol fighter is growing--a lot.A review by Reuters has found ... [Published FiercePharma - Aug 08 2014]
First reported Aug 02 2014 - Updated Aug 02 2014 - 1 reports

The Merry Old Land Of Oz

(HealthNewsDigest.com) - The career path of Dr. Mehmet Oz is most puzzling.  Boasting a fine education (Tower Hill prep; Harvard undergrad; Penn med school; and Wharton), Oz did his residency at New York's Columbia-Presbyterian Medical Center, and is ... [Published HealthNewsDigest.com - Aug 02 2014]
First reported Jul 23 2014 - Updated Jul 23 2014 - 1 reports

Keller Rohrback L.L.P. Investigates Allegations of Severe Side Effects Caused by Xarelto

SEATTLE, (GLOBE NEWSWIRE) -- Attorney Advertising. Keller Rohrback L.L.P. is investigating claims that Xarelto (rivaroxaban), an anticoagulant drug used both to treat and prevent blood clots, causes serious and unrestrained internal bleeding which could ... [Published OSIX News - Jul 23 2014]
First reported May 30 2014 - Updated May 30 2014 - 1 reports

There Are Still Lipitor Rhabdo Cases?

Imagine our surprise at learning that people are still filing cases alleging rhabdomyolysis resulting from Lipitor use.  Lipitor is the best known prescription drug ever (except maybe for Viagra), and the association between rhabdomyolysis and statins ... [Published Drug and Device Law - May 30 2014]
First reported May 29 2014 - Updated May 29 2014 - 1 reports

Louisiana: When MedMal Is Not Enough

Things are often done differently down in Louisiana.  For one thing, Louisiana is the nation’s only civil law state.  It’s also the only state not to have enacted the Uniform Commercial Code.  We bloggedabout one such difference before – the state’s ... [Published Drug and Device Law - May 29 2014]

Quotes

...know how thin your blood is and whether you are in the 'goldilocks' range of anti-coagulation," said Daniel Mensher, a Keller Rohrback attorney. "While the no-testing claims are great for the company's marketing department, taking this drug without adequate testing is simply too risky."
When the labeling change was released in 2012, a top FDA official underscored that the agency still stood behind the drugs: "Clearly, we think that the heart benefit of statins outweighs this small increased risk (for diabetes)" Amy Egan, a deputy director for safety at the agency's Division of Metabolism and Endocrinology, said in a statement at the time

More Content

All (9) | News (7) | Reports (0) | Blogs (2) | Audio/Video (0) | Fact Sheets (0) | Press Releases (0)
sort by: Date | Relevance
Keller Rohrback L.L.P. Investigates Life-Threat... [Published SPi World News - Aug 26 2014]
Pfizer sued for hiding side-effects of choleste... [Published Sott.net - Aug 19 2014]
Pfizer (NYSE:PFE) Seeing a Surge Of Lawsuits Ov... [Published Live Trading News - Aug 09 2014]
Pfizer faces growing legal threat over Lipitor [Published FiercePharma - Aug 08 2014]
INSIGHT-Pfizer confronts surge of lawsuits over... [Published Reuters - Aug 08 2014]
The Merry Old Land Of Oz [Published HealthNewsDigest.com - Aug 02 2014]
Keller Rohrback L.L.P. Investigates Allegations... [Published OSIX News - Jul 23 2014]
There Are Still Lipitor Rhabdo Cases? [Published Drug and Device Law - May 30 2014]
Louisiana: When MedMal Is Not Enough [Published Drug and Device Law - May 29 2014]
1
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
There Are Still Lipitor Rhabdo Cases? [Published Drug and Device Law - May 30 2014]
Imagine our surprise at learning that people are still filing cases alleging rhabdomyolysis resulting from Lipitor use.  Lipitor is the best known prescription drug ever (except maybe for Viagra), and the association between rhabdomyolysis and statins ...
Louisiana: When MedMal Is Not Enough [Published Drug and Device Law - May 29 2014]
Things are often done differently down in Louisiana.  For one thing, Louisiana is the nation’s only civil law state.  It’s also the only state not to have enacted the Uniform Commercial Code.  We bloggedabout one such difference before – the state’s ...
1
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.